Patrick G. Kehoe

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint”.

The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint

The Lancet Regional Health - Europe(2023)10.1016/j.lanepe.2023.100657

N/A

0.724DataRank · unranked

124 citations

Anders Wimo, Ron Handels, Gunilla Johansson, Mercè Boada, Sebastiaan Engelborghs +11 more

Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease

JAMA Neurology(2022)10.1001/jamaneurol.2022.1166

N/A

0.681DataRank · unranked

93 citations

Michaël E. Belloy, Benjamin Grenier‐Boley, Itziar de Rojas, Atahualpa Castillo-Morales, Iris E. Jansen +95 more

Baseline Results: The Association Between Cardiovascular Risk and Preclinical Alzheimer’s Disease Pathology (ASCEND) Study

Journal of Alzheimer s Disease(2020)10.3233/jad-191103

N/A

0.494DataRank · unranked

26 citations

Hanfeng Huang, Liping Zhao, Danielle D. Verble, Alexandra Nutaitis, Sonum Tharwani +10 more

Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping

Alzheimer s Research & Therapy(2022)10.1186/s13195-022-00962-4

N/A

0.464DataRank · unranked

21 citations

Sarah J. Eger, Yann Le Guen, Vincent Damotte, Shahzad Ahmad, M Arfan Ikram +24 more

A novel Alzheimer disease locus located near the gene encoding tau protein

UNC Libraries(2020)10.17615/7php-8b80

N/A

0.292DataRank · unranked

6 citations

Thomas Bird, DeStefano, Hanon, Tárraga, Allan I. Levey +95 more

Challenges at the APOE locus: A robust quality control approach for accurate APOE genotyping

medRxiv(2021)10.1101/2021.10.19.21265022

N/A

0.165DataRank · unranked

2 citations

Sarah J. Eger, Yann Le Guen, Vincent Damotte, Shahzad Ahmad, M Arfan Ikram +24 more

Elevated Na + /K + Ratio in Alzheimer’s Disease: A Potential Biomarker for Braak Stage

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.11.04.686539

N/A

0.104DataRank · unranked

1 citations

Shiyue Pan, Tong Zhou, Patrick G. Kehoe, Yumei Feng, Yuma Mizuno

Polygenic Hazard Score for Predicting Age-associated Risk of Alzheimer’s Disease in European Populations: Development and Validation

medRxiv(2025)10.1101/2025.07.28.25332293

N/A

0.104DataRank · unranked

1 citations

Shahram Bahrami, Espen Hagen, Julian Fuhrer, Vera Fominykh, Alexey Shadrin +95 more

Comment by European Alzheimer’s Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer’ s disease

The Journal of Prevention of Alzheimer s Disease(2025)10.1016/j.tjpad.2025.100259

N/A

0DataRank · unranked

0 citations

Javier Arbizu, Mercè Boada, Mircea Balasa, Karim Bennys, Marina Boban +47 more

Association of combination statin and antihypertensive therapy with reduced Alzheimer’s disease and related dementia risk

PLoS ONE(2020)10.1371/journal.pone.0229541

N/A

0DataRank · unranked

58 citations

Geoffrey Joyce, Roberta Dı́az Brinton, Whitney Wharton, Patrick G. Kehoe, Julie Zissimopoulos +1 more

Small RNA modifications in Alzheimer’s disease

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.30.071100

N/A

0DataRank · unranked

0 citations

Fatima Trebak, Lucas AC Souza, Junchao Shi, Tong Zhou, Patrick G. Kehoe +3 more

Losartan to slow the progression of mild-to-moderate Alzheimer’s disease through angiotensin targeting: the RADAR RCT

Efficacy and Mechanism Evaluation(2021)10.3310/eme08190

N/A

0DataRank · unranked

8 citations

Nicholas Turner, Beth Howden, Lina Jarutyt, Shona Clegg, Ian B. Malone +16 more

The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?

Alzheimer s & Dementia(2021)10.1002/alz.12393

N/A

0DataRank · unranked

11 citations

Hiroko H. Dodge, Sarah‐Naomi James, Gregory A. Jicha, Pierre‐François Meyer, Marcus Richards +9 more

Small RNA modifications in Alzheimer's disease

Neurobiology of Disease(2020)10.1016/j.nbd.2020.105058

N/A

0DataRank · unranked

76 citations

Fatima Trebak, Lucas A. C. Souza, Junchao Shi, Tong Zhou, Patrick G. Kehoe +3 more